12周的富含素的饮食对新陈代谢和内分泌的影响
Kevin B Cayabyab1, Marley J Shin1, Micah S Heimuli1
1Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA.
Nutrients
|June 27, 2024
概括
粉补充剂改善了肥胖和2型糖尿病的老鼠的代谢健康. 这种罕见的糖减少了体重增加,增强了胰岛素敏感性,并控制了血糖水平.
科学领域:
- 代谢健康 代谢健康
- 营养科学 营养科学
- 内分泌学 在内分泌学.
背景情况:
- 全球2型糖尿病 (T2D) 和肥胖的患病率正在上升.
- 需要新的饮食策略来管理代谢障碍.
- 阿卢洛斯是一种罕见的糖,显示出降低血糖的潜力.
研究的目的:
- 研究粉对大鼠饮食引起的肥胖和T2D的影响.
- 假设粉可以改善体重,胰岛素敏感性和血糖控制.
- 在12周的时间内评估粉对代谢标记物的影响.
主要方法:
- 使用了一种与饮食诱导的肥胖和T2D的老鼠模型.
- 在12周的时间内服用过素补充剂.
- 监测体重,食物消耗,胰岛素敏感性和葡萄糖调节.
主要成果:
- 艾卢洛斯减轻了高脂肪,高糖饮食的不良影响.
- 观察到减轻体重增加和改善胰岛素抵抗在粉组.
- 观察到食物消耗减少和葡萄糖类-1 (GLP-1) 水平增加,增强葡萄糖调节和食欲控制.
- 防止了肝脏甘油三积累,促进了脂肪组织中的线粒体脱.
结论:
- 粉补充剂显示了改善代谢健康标志物的潜力.
- 粉是一种有前途的饮食成分,用于控制肥胖和T2D.
- 需要进一步的研究来探索粉在预防代谢性疾病中的长期益处和机制.
相关概念视频
Overview of Carbohydrate Metabolism
896
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
896
Metabolic States of the Body: The Absorptive State
676
During the absorptive state, which lasts approximately four hours after a meal, the body absorbs nutrients from the gastrointestinal tract. The carbohydrates, proteins, and lipids we consume are broken down into monosaccharides, amino acids, and free fatty acids for absorption. While carbohydrates and proteins are absorbed as-is, lipids are absorbed in their broken-down forms and then re-esterified into triglycerides within enterocytes before being packaged into chylomicrons. These absorbed...
676
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
169
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
169
Metabolic States of the Body: The Postabsorptive State
294
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
294
Glucose Homeostasis: Regulation of Blood Glucose
1.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.6K
Insulin: Dosing Regimen and Adverse Effects
165
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165


